Marshall Wace LLP Purchases 116,496 Shares of Trupanion, Inc. (NASDAQ:TRUP)

Marshall Wace LLP lifted its position in shares of Trupanion, Inc. (NASDAQ:TRUP) by 11.9% during the second quarter, Holdings Channel.com reports. The institutional investor owned 1,094,589 shares of the financial services provider’s stock after acquiring an additional 116,496 shares during the quarter. Marshall Wace LLP’s holdings in Trupanion were worth $32,181,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in TRUP. Sivia Capital Partners LLC bought a new position in Trupanion in the fourth quarter worth approximately $31,398,000. 8 Knots Management LLC purchased a new position in shares of Trupanion in the 4th quarter valued at $21,165,000. Wellington Management Group LLP raised its position in shares of Trupanion by 34.6% in the 4th quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider’s stock worth $74,862,000 after acquiring an additional 630,155 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Trupanion during the 2nd quarter worth $4,739,000. Finally, Hosking Partners LLP bought a new stake in Trupanion during the second quarter valued at about $3,523,000.

Insider Activity at Trupanion

In other news, CFO Fawwad Qureshi sold 640 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $43.12, for a total transaction of $27,596.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Trupanion news, CFO Fawwad Qureshi sold 640 shares of the company’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $43.12, for a total value of $27,596.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,764 shares of company stock worth $405,238. 5.50% of the stock is owned by corporate insiders.

Trupanion Trading Up 1.6 %

Shares of Trupanion stock opened at $42.72 on Friday. The stock has a market cap of $1.80 billion, a PE ratio of -66.75 and a beta of 1.74. The firm has a fifty day moving average price of $41.04 and a 200 day moving average price of $32.00. Trupanion, Inc. has a 1 year low of $19.14 and a 1 year high of $49.14. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings data on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.04. The business had revenue of $314.80 million during the quarter, compared to analyst estimates of $309.33 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The company’s revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the business posted ($0.33) EPS. Equities research analysts predict that Trupanion, Inc. will post -0.34 earnings per share for the current year.

Wall Street Analyst Weigh In

TRUP has been the topic of several analyst reports. Bank of America lifted their target price on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research note on Friday, September 20th. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Northland Securities increased their target price on shares of Trupanion from $35.00 to $45.00 and gave the company a “market perform” rating in a research report on Thursday, September 19th. Piper Sandler raised their target price on shares of Trupanion from $30.00 to $38.00 and gave the company a “neutral” rating in a research note on Friday, August 9th. Finally, William Blair assumed coverage on Trupanion in a research report on Friday, July 19th. They set an “outperform” rating on the stock. Four investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $40.67.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.